Cargando…

CD19嵌合抗原受体T细胞治疗病灶大于7.5 cm的复发/难治B细胞淋巴瘤肿瘤局部反应与疗效分析

OBJECTIVE: To observe the local reactions and efficacy of CD19 CAR-T therapy in recurrence/refractory B-cell non-Hodgkin's lymphoma (R/R NHL) patients with >7.5 cm lesions. METHODS: 32 R/R NHL patients with >7.5 cm lesions were enrolled and injected with CD19 CAR-T cells. Flow cytometry w...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408490/
https://www.ncbi.nlm.nih.gov/pubmed/34455744
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.07.007